Search Results - "Dapagliflozin"

1

New drugs in diabetes

by H N Rajaratnam, S A Kahandawa
Published 2012-05-01

Subjects: “...dapagliflozin...”

Get full text

Article

2

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metf...

by Schwartz SS, Katz A
Published 2016-03-01

Subjects: “...dapagliflozin...”

Get full text

Article

3

Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK

by Kun-Ling Tsai, Pei-Ling Hsieh, Wan-Ching Chou, Hui-Ching Cheng, Yu-Ting Huang, Shih-Hung Chan
Published 2021-02-01

Subjects: “...Dapagliflozin...”

Get full text

Article

4

$Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia–Pacific region$

Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia–Pacific region

by Chia-Te Liao, Chun-Ting Yang, Han Siong Toh, Wei-Ting Chang, Hung-Yu Chang, Fang-Hsiu Kuo, Mei-Chuan Lee, Yi-Ming Hua, Hsin-Ju Tang, Carol Strong, Huang-Tz Ou
Published 2021-10-01

Subjects: “...Dapagliflozin...”

Get full text

Article

5

The beneficial effects of dapagliflozin on the course of experimental urate nephrolithiasis

by V. Yu. Perfil’ev, Ya. F. Zverev, A. Yu. Zharikov, D. Yu. Luk’yanenko, I. V. Lysenko, O. Sh. Atabaeva
Published 2017-04-01

Subjects: “...dapagliflozin...”

Get full text

Article

6

$Cost‐effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China$

Cost‐effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China

by Younan Yao, Rongcheng Zhang, Tao An, Xinke Zhao, Jian Zhang
Published 2020-12-01

Subjects: “...Dapagliflozin...”

Get full text

Article

7

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial

by Mariëlle Scheffer, Annet Driessen‐Waaijer, Nazha Hamdani, Jochem W.D. Landzaat, Nini H. Jonkman, Walter J. Paulus, Loek vanHeerebeek
Published 2020-12-01

Subjects: “...Dapagliflozin...”

Get full text

Article

8

Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completio...

by Milton Packer
Published 2019-10-01

Subjects: “...Dapagliflozin...”

Get full text

Article

9

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study

by Fumika Shigiyama, Naoki Kumashiro, Masahiko Miyagi, Kayoko Ikehara, Eiichiro Kanda, Hiroshi Uchino, Takahisa Hirose
Published 2017-07-01

Subjects: “...Dapagliflozin...”

Get full text

Article

10

Practice of Dapagliflozin Application in Patients with Type 2 Diabetes Mellitus

by L.V. Shkala, Ya.I. Kleban, O.V. Cherpak, O.V. Shkala, O.A. Karapetian, T.H. Volkovska
Published 2015-08-01

Subjects: “...dapagliflozin...”

Get full text

Article

11

$Acute pleiotropic effects of dapagliflozin in type 2 diabetic patients with heart failure with reduced ejection fraction: a crossover trial$

Acute pleiotropic effects of dapagliflozin in type 2 diabetic patients with heart failure with reduced ejection fraction: a crossover trial

by Fahmida Ilyas, Lynette Jones, Su Ling Tee, Matthew Horsfall, Amy Swan, Fiona Wollaston, Tracy Hecker, Carla De Pasquale, Simeoni Thomas, William Chong, Steve Stranks, Arduino A. Mangoni, Joseph B. Selvanayagam, Derek P. Chew, Carmine G. De Pasquale
Published 2021-10-01

Subjects: “...Dapagliflozin...”

Get full text

Article

12

Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway

by Liuran Li, Qinghua Li, Wenbin Huang, Yibing Han, Huiting Tan, Min An, Qianru Xiang, Rui Zhou, Li Yang, Li Yang, Yanzhen Cheng
Published 2021-05-01

Subjects: “...dapagliflozin...”

Get full text

Article

13

Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of anti-diabetic agents

by Eva M Vivian
Published 2014-12-01

Subjects: “...oral; canagliflozin; dapagliflozin; diabetes mellitus...”

Get full text

Article

14

Improved Manufacturability and In Vivo Comparative Pharmacokinetics of Dapagliflozin Cocrystals in Beagle Dogs and Human Volunteers

by Sangho Cho, Jeongwook Lee, Yongwon Yoo, Minyong Cho, Seil Sohn, Beom-Jin Lee
Published 2021-01-01

Subjects: “...dapagliflozin...”

Get full text

Article

15

Management of Diabetes Associated with Nephrotic Syndrome: Therapeutic Potential of Dapagliflozin for Protracted Volume Retention

by Toshimi Imai, Tetsu Akimoto, Chiharu Ito, Takahiro Masuda, Daisuke Nagata
Published 2015-11-01

Subjects: “...dapagliflozin...”

Get full text

Article

16

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction

by Ayman Ibrahim, Ramadan Ghaleb, Hossam Mansour, Amr Hanafy, Naggeh M. Mahmoud, Mohamed Abdelfatah Elsharef, Mohamed Kamal Salama, Saud M. Elsaughier, Lobna Abdel-Wahid, Mona Embarek Mohamed, Ahmed K. Ibrahim, Ahmed Abdel-Galeel
Published 2020-12-01

Subjects: “...dapagliflozin...”

Get full text

Article

17